368 related articles for article (PubMed ID: 33964485)
1. Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: A systematic review of 235 cases.
Meena DS; Kumar D; Bohra GK; Kumar G
Infect Dis Now; 2021 Nov; 51(8):654-660. PubMed ID: 33964485
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system aspergillosis in immunocompetent patients: Case series and literature review.
Ma Y; Li W; Ao R; Lan X; Li Y; Zhang J; Yu S
Medicine (Baltimore); 2020 Oct; 99(44):e22911. PubMed ID: 33126348
[TBL] [Abstract][Full Text] [Related]
3. [Effects of voriconazole and vascular lesions in invasion of aspergillosis into the central nerve system].
Ueno A; Hamano T; Fujii A; Matsunaga A; Naganuma S; Yoneda M; Itoh H; Kuriyama M
Rinsho Shinkeigaku; 2009 Aug; 49(8):468-73. PubMed ID: 19827595
[TBL] [Abstract][Full Text] [Related]
4. Update on the treatment of cerebral aspergillosis.
Schwartz S; Thiel E
Ann Hematol; 2004; 83 Suppl 1():S42-4. PubMed ID: 15124667
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
[TBL] [Abstract][Full Text] [Related]
6. Aspergillosis of central nervous system in patients with leukemia and stem cell transplantation: a systematic review of case reports.
Shariati A; Didehdar M; Rajaeih S; Moradabadi A; Ghorbani M; Falahati V; Chegini Z
Ann Clin Microbiol Antimicrob; 2021 Jun; 20(1):44. PubMed ID: 34130699
[TBL] [Abstract][Full Text] [Related]
7. Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.
Hoenigl M; Krause R
Curr Pharm Des; 2013; 19(20):3648-68. PubMed ID: 23278539
[TBL] [Abstract][Full Text] [Related]
8. Chronic Invasive Aspergillus Sinusitis and Otitis with Meningeal Extension Successfully Treated with Voriconazole.
Morgand M; Rammaert B; Poirée S; Bougnoux ME; Tran H; Kania R; Chrétien F; Jouvion G; Lortholary O
Antimicrob Agents Chemother; 2015 Dec; 59(12):7857-61. PubMed ID: 26392507
[TBL] [Abstract][Full Text] [Related]
9. Invasive cerebral aspergillosis in non-neutropenic patients: A case series from Western India.
Samantaray S; Kumar D; Meena DS; Bohra GK; Akshatha R; Jain V; Tiwari S; Balamurugan T; Midha N; Garg MK
J Mycol Med; 2023 May; 33(2):101380. PubMed ID: 37031499
[TBL] [Abstract][Full Text] [Related]
10. Recurrent Stroke and Fatal Ruptured Mycotic Aneurysm Caused by Invasive
Mian I; Ives S; Jean-Louis G; Laczniak A
WMJ; 2021 Apr; 120(1):82-84. PubMed ID: 33974773
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis.
Reinwald M; Buchheidt D; Hummel M; Duerken M; Bertz H; Schwerdtfeger R; Reuter S; Kiehl MG; Barreto-Miranda M; Hofmann WK; Spiess B
PLoS One; 2013; 8(2):e56706. PubMed ID: 23451071
[TBL] [Abstract][Full Text] [Related]
12. Aspergillosis infection over 20 years: a case report of probable vascular invasion in central nervous system.
Zhang Y; Wu X; Hu YP
BMC Neurol; 2020 Sep; 20(1):342. PubMed ID: 32917165
[TBL] [Abstract][Full Text] [Related]
13. CNS aspergillosis with mycotic aneurysm, cerebral granuloma and infarction.
Ho CL; Deruytter MJ
Acta Neurochir (Wien); 2004 Aug; 146(8):851-6. PubMed ID: 15254808
[TBL] [Abstract][Full Text] [Related]
14. Invasive rhino-orbital-cerebral aspergillosis in an immunocompetent patient.
Leroy J; Vuotto F; Le V; Cornu M; François N; Marceau L; Fichet C; Loridant S; Sendid B
J Mycol Med; 2020 Sep; 30(3):101002. PubMed ID: 32507472
[TBL] [Abstract][Full Text] [Related]
15. Prolonged survival of a patient with AIDS and central nervous system aspergillosis.
Hidron AI; Gongora MC; Anderson AM; Diazgranados CA
Med Mycol; 2009 May; 47(3):327-30. PubMed ID: 19212896
[TBL] [Abstract][Full Text] [Related]
16. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
[TBL] [Abstract][Full Text] [Related]
17. Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort.
Spapen H; Spapen J; Taccone FS; Meersseman W; Rello J; Dimopoulos G; Charles PE; Rao R; Pérez M; Martin C; Vogelaers D; Blot SI;
Int J Antimicrob Agents; 2014 Feb; 43(2):165-9. PubMed ID: 24315314
[TBL] [Abstract][Full Text] [Related]
18. Response of central nervous system aspergillosis to voriconazole.
Balasubramaniam P; Madakira PB; Ninan A; Swaminathan A
Neurol India; 2007; 55(3):301-3. PubMed ID: 17921662
[TBL] [Abstract][Full Text] [Related]
19. Isolated renal and urinary tract aspergillosis: a systematic review.
Bongomin F; Morgan B; Ekeng BE; Mushi MF; Kibone W; Olum R; Meya DB; Hamer DH; Denning DW
Ther Adv Urol; 2023; 15():17562872231218621. PubMed ID: 38130371
[TBL] [Abstract][Full Text] [Related]
20. CNS aspergillosis: recognition, diagnosis and management.
Ruhnke M; Kofla G; Otto K; Schwartz S
CNS Drugs; 2007; 21(8):659-76. PubMed ID: 17630818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
